Lab
Total Renal Laboratories INC
Total Renal Laboratories INC was paid $37.73M by Medicaid between Oct 2018 and Dec 2024, across 90 billing codes. Its largest line is 83970, — 32% of everything it billed.
33Billing provider infoTOTAL RENAL LABORATORIES INC
DELAND, FL 32724
DELAND, FL 32724
33aNPI1245720820assigned 05/18/2018
33bProvider typeClinical Medical Laboratory
28Total paid$37.73M
24GClaims6,020,334
24DCodes billed90
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#5 of 225
Median peer was paid$74K
This provider vs. median513×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,722 | $81K | |
| 2019 | 641,496 | $3.90M | |
| 2020 | 1,015,949 | $6.78M | |
| 2021 | 1,263,584 | $7.82M | |
| 2022 | 1,237,540 | $7.54M | |
| 2023 | 1,020,023 | $6.38M | |
| 2024incomplete | 824,020 | $5.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 83970 | 32% | 433,311 | 374,252 | $12.01M | |
| 82728 | 8.0% | 338,570 | 283,351 | $3.01M | |
| 83550 | 5.7% | 377,029 | 328,290 | $2.13M | |
| 84460 | 5.7% | 1,059,966 | 951,723 | $2.13M | |
| 83540 | 4.5% | 386,473 | 330,700 | $1.71M | |
| 83615 | 4.5% | 464,875 | 418,215 | $1.68M | |
| 86803 | 4.0% | 155,470 | 142,447 | $1.52M | |
| 84450 | 3.5% | 467,476 | 419,237 | $1.33M | |
| 87340 | 3.4% | 182,651 | 160,814 | $1.29M | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.9% | 233,818 | 210,791 | $1.11M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.8% | 50,998 | 44,566 | $1.04M |
| 82310 | 2.2% | 274,718 | 192,883 | $846K |
78 more codes
| 82108 | 2.2% | 49,090 | $842K | |
| 84100 | 2.1% | 308,036 | $804K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 17,122 | $657K |
| 80061 | Lipid panel | 1.7% | 82,072 | $635K |
| 86706 | 1.4% | 72,539 | $524K | |
| 84295 | 1.2% | 141,473 | $438K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 63,446 | $376K |
| 86704 | <1% | 38,489 | $318K | |
| 87522 | Neg quan hep c or qual rna | <1% | 12,829 | $258K |
| 84520 | <1% | 114,228 | $232K | |
| 85045 | <1% | 71,043 | $218K | |
| 80051 | <1% | 45,995 | $218K | |
| 82746 | <1% | 20,940 | $217K | |
| 85018 | <1% | 105,482 | $177K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17,723 | $176K |
| 82040 | <1% | 47,634 | $152K | |
| 82570 | <1% | 37,402 | $146K | |
| 82607 | <1% | 14,252 | $144K | |
| 83735 | <1% | 32,324 | $141K | |
| 82565 | <1% | 38,540 | $118K | |
| 84132 | <1% | 41,265 | $113K | |
| 84466 | <1% | 11,123 | $104K | |
| 87040 | <1% | 12,687 | $97K | |
| 83718 | <1% | 14,367 | $82K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 10,167 | $79K |
| 84075 | <1% | 20,328 | $66K | |
| 80202 | <1% | 6,185 | $61K | |
| 82435 | <1% | 19,722 | $53K | |
| 84540 | <1% | 16,055 | $50K | |
| 84155 | <1% | 20,628 | $47K | |
| 85610 | <1% | 9,149 | $36K | |
| 87186 | <1% | 5,385 | $31K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,036 | $28K |
| 87070 | <1% | 4,376 | $26K | |
| 82945 | <1% | 8,029 | $24K | |
| 82247 | <1% | 7,002 | $23K | |
| 82374 | <1% | 8,860 | $22K | |
| 80069 | <1% | 2,637 | $20K | |
| 89051 | <1% | 4,480 | $16K | |
| 87205 | <1% | 4,188 | $12K | |
| 87077 | <1% | 1,944 | $11K | |
| 82977 | <1% | 1,710 | $10K | |
| 84478 | <1% | 2,196 | $9K | |
| 84550 | <1% | 2,950 | $9K | |
| 82947 | <1% | 2,600 | $8K | |
| 82465 | <1% | 2,799 | $8K | |
| 82248 | <1% | 2,900 | $8K | |
| 84439 | <1% | 1,072 | $7K | |
| 87147 | <1% | 1,938 | $7K | |
| 86140 | <1% | 2,346 | $7K | |
| 84153 | <1% | 577 | $7K | |
| 80076 | <1% | 1,597 | $7K | |
| 85049 | <1% | 2,645 | $6K | |
| ATP02 | <1% | 1,022 | $6K | |
| 80197 | <1% | 149 | $5K | |
| 84436 | <1% | 1,215 | $5K | |
| 82652 | <1% | 127 | $3K | |
| 82274 | <1% | 288 | $2K | |
| 85014 | <1% | 1,643 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 419 | $2K |
| 87341 | <1% | 334 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 307 | $2K |
| 82550 | <1% | 244 | $1K | |
| 84479 | <1% | 311 | $1K | |
| 84480 | <1% | 88 | $747.08 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 28 | $728.42 |
| 85048 | <1% | 862 | $674.59 | |
| 85046 | <1% | 158 | $637.56 | |
| 85041 | <1% | 685 | $437.04 | |
| 87517 | <1% | 15 | $430.02 | |
| 81001 | <1% | 146 | $286.34 | |
| 85027 | <1% | 101 | $239.47 | |
| 84481 | <1% | 15 | $126.69 | |
| 87102 | <1% | 29 | $126.17 | |
| 83010 | <1% | 61 | $122.50 | |
| ATP04 | <1% | 68 | $86.88 | |
| ATP03 | <1% | 56 | $6.85 | |
| 99080 | 0% | 1,006 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWAGNER, KERI (VP - GENERAL MANAGER)
Parent organizationTOTAL RENAL CARE INC